{"id":"W2950140656","doi":"10.1093/ndt/gfz106.fp482","title":"FP482EGFR LOSS WITH GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUE TREATMENT: DATA FROM SUSTAIN 6 AND LEADER","year":2019,"lang":"en","type":"article","venue":"Nephrology Dialysis Transplantation","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"","keywords":"Medicine; Glucagon-like peptide-1; Glucagon; Glucagon-like peptide-2; Internal medicine; Peptide; Endocrinology; Diabetes mellitus; Intensive care medicine; Insulin; Type 2 diabetes; Biochemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005384397,0.0006253488,0.002011666,0.0002767267,0.000173791,0.0006971433,0.0004571932,0.0005574811,0.002786667],"category_scores_gemma":[0.005099888,0.0001716833,0.003225902,0.0004266318,0.000364437,0.0006492343,0.0003615091,0.001098302,0.0004110164],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000372061,"about_ca_system_score_gemma":0.0006649034,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006145234,"about_ca_topic_score_gemma":0.0008891636,"domain_scores_codex":[0.9982638,0.0009476013,0.0001665704,0.0002214548,0.0002879959,0.0001125772],"domain_scores_gemma":[0.9959778,0.00180595,0.001167455,0.0003354194,0.0003752391,0.0003382158],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8194674,0.001885411,0.04275541,0.00227553,0.01064113,0.0001478886,0.0001346683,0.001992075,0.003753684,0.0001545958,0.003504091,0.1132881],"study_design_scores_gemma":[0.2245622,0.3352854,0.3919883,0.0006427797,0.02063571,0.001042649,0.000207763,0.00464964,0.007738594,0.000999672,0.01208907,0.0001582676],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9826403,0.01185507,0.0006068041,0.0003281874,0.00007101416,0.0001875417,0.002212525,0.00009065316,0.002007842],"genre_scores_gemma":[0.9913219,0.003064645,0.0004786576,0.0003008581,0.0001170567,0.0001647622,0.003751169,0.00002577768,0.0007752053],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005384397,"threshold_uncertainty_score":0.02847576,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04586588664891668,"score_gpt":0.3248893250956541,"score_spread":0.2790234384467374,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}